In a mouse model, researchers found that different probiotic strains can either accelerate or delay the gut microbiome's recovery after antibiotic treatment. The work adds to the body of evidence ...

Sea turtles are considered crucial bioindicators of marine environmental health due to their extensive lifespans, long-distance migrations, and frequent presence in sensitive coastal zones. A ...

Antibiotic sensitivity tests revealed that approximately 95% of the bacteria were resistant to cefazolin, about 50% to ampicillin, and roughly 45% to amoxicillin-clavulanate—all antibiotics ...

An international study by Michigan State University and partner researchers has uncovered a hidden danger lurking in animal farms around the world: Livestock manure is packed with antibiotic ...

Scientists from the UK and South Africa have discovered a surprising new role for a commonly-used antibiotic that could open the door to a new family of improved therapies for high blood pressure ...

The recall was initiated after it was reported that black spots were observed on the tablet surface.

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh phase 3 readout.

Microbiologist Michael Baym studies antibiotic resistance at Harvard Medical School. He lost millions in federal funding this week.

A pill developed by GSK was found to be safe and effective in treating gonorrhea. It could be the first new type of antibiotic for the STI in more than 20 years.

Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

The FDA approved a new antibiotic for UTIs from drugmaker GSK. The drug, Blujepa, is for women and girls ages 12 and up.